Healthcare System to Acquire IBA Molecular North America, Inc., Expands Nuclear Medicine Footprint

Decatur, IL (PRWEB) April 20, 2015 Illinois Health and Science (IHS) announced that it has signed a definitive agreement to acquire IBA Molecular North America, Inc. (IBAM NA), the US subsidiary of IBA Molecular. The acquisition includes all IBAM NA’s cyclotron sites and its research and development facilities. IBA Molecular is a global radiopharmaceutical business ...

World Molecular Diagnostics Market Is Expected To Grow To $8,020.1 Million From 2014 To 2020: Grand View Research, Inc

World Molecular Diagnostics Market Is Expected To Grow To $8,020.1 Million From 2014 To 2020: Grand View Research, Inc
San Francisco, CA (PRWEB) August 26, 2014 The global market for molecular diagnostics is expected to reach USD 8,020.1 million by 2020, according to a new study by Grand View Research, Inc. Growing demand for personalized medicine and theranostics, and the subsequent introduction of advanced cancer diagnostic technologies are expected to be key factors driving ...

AJMC Panel Sees Advantages in FDA Regulation of Molecular Diagnostic Tests for Cancer Care

AJMC Panel Sees Advantages in FDA Regulation of Molecular Diagnostic Tests for Cancer Care
PLAINSBORO, N.J. (PRWEB) February 27, 2015 The clinical director of the Breast Oncology Program at the University of Michigan sees great promise in the FDA’s plans to regulate molecular diagnostic testing in cancer care, and called on third-party payers to support bringing rigor to the field by reimbursing those tests that pass regulatory muster. ...

Pre-Clinical Molecular Imaging Market to Hit $797 Million by 2019 – Reported by MarketsandMarkets

Pre-Clinical Molecular Imaging Market to Hit $797 Million by 2019 - Reported by MarketsandMarkets
(PRWEB) February 25, 2015 According to the report published by MarketsandMarkets pre-clinical imaging has witnessed significant importance in the drug discovery and development in recent times. Development of technologically advanced and multi-modality preclinical imaging systems is considered to be some of the strong driving factors for this market. According to the report increased adoption of ...

Molecular Weight Marker Market worth $472.47 Million by 2019 – New Report by MarketsandMarkets

Molecular Weight Marker Market worth $472.47 Million by 2019 - New Report by MarketsandMarkets
(PRWEB) February 16, 2015 Molecular weight markers are widely used in life science research. Increased research and development spending by biotechnology companies, government and private sector funding for research and growing partnership between academic, biotechnology & pharmaceutical companies for molecular research will drive the growth of the this market. The global molecular weight markers ...

Global Molecular Diagnostics Market Is Expected To Be Worth $8,020.1 million by 2020: Grand View Research, Inc.

Global Molecular Diagnostics Market Is Expected To Be Worth $8,020.1 million by 2020: Grand View Research, Inc.
San Francisco, California (PRWEB) September 30, 2014 The global market for molecular diagnostics is expected to reach USD 8,020.1 million by 2020, according to a new study by Grand View Research, Inc. Growing demand for personalized medicine and theranostics, and the subsequent introduction of advanced cancer diagnostic technologies are expected to be key factors driving ...

Gamma Medica Selects Intelemage for Secure Cloud-Based Molecular Breast Image Registry

CINCINNATI, OH (PRWEB) November 21, 2014 Gamma Medica, Inc., a leader in molecular breast imaging, has partnered with Intelemage LLC, a pioneer in secure medical image exchange solutions, to provide a molecular breast imaging and data repository. Physicians utilizing molecular breast imaging (MBI) have historically collaborated and exchanged MBI cases for education and clinical decision ...